J&J acquires Abbott Medical Optics

Johnson & Johnson has announced the completion of its acquisition of ophthalmics company Abbott Medical Optics (AMO).

The $4.325 bn (£3.535bn) acquisition was first announced last September and encompasses ophthalmic products in three areas of patient care – cataract surgery, laser refractive surgery and consumer eye health.

With the acquisition completed, these product lines will now join with the Acuvue brand contact lens business, and the combined organisation will operate under Johnson & Johnson Vision.

Following the acquisition, J&J company group chairmain, Ashley McEvoy, said: “With the addition of AMO’s world-renowned ophthalmic surgery business, J&J Vision is poised to become a world leader in eye health.

“Sight is precious, it’s the sense people fear losing the most. By bringing on board surgical solutions that are supported by the resources and global reach of J&J, we can improve and restore sight for more patients across the globe.”